Stock Events

Stock Events

Search...

MoonLake Immunotherapeutics (MLTX) Q3 2024 Earnings

7AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.39

-0.26

-0.13

0

Details

Expected EPS

-0.276921

Actual EPS

-0.39

Surprise EPS

-0.11

Surprise Percent

+40.83%

Description

MoonLake Immunotherapeutics (MLTX) has reported earnings of -0.39 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.